What monitoring parameter is essential when administering aminoglycosides?

• A. Monitor liver enzymes
• B. Monitor renal function and drug levels
• C. Monitor electrolytes only
• D. Monitor thyroid function

Answer: (B)

Aminoglycosides have a narrow therapeutic window and are eliminated by the kidneys, so tracking what the kidneys are doing and how much drug is present in the body is essential. Monitoring renal function is crucial because nephrotoxicity is a major adverse effect; rising creatinine, reduced GFR, or low urine output signal that the drug may be accumulating and causing harm. Dosing often needs adjustment based on kidney function to prevent buildup.

Monitoring drug levels is equally important to balance efficacy with toxicity. Measuring trough concentrations just before the next dose helps ensure levels stay low enough to minimize toxicity, while peak levels (when used) can confirm adequate tissue penetration for a robust bactericidal effect. Adjustments to dose or dosing interval are guided by these levels and the patient’s renal function.

Other parameters like liver enzymes or thyroid function aren’t the primary concerns with aminoglycosides, and electrolyte monitoring alone doesn’t address the risk of drug accumulation. So, renal function assessment together with drug level monitoring is the essential pair when administering aminoglycosides.